Brian C. Stephenson, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 7,200 shares at $29.31 ($211K) on 2020-06-01, disclosed to the SEC on 2020-06-03.
Open-market sale of $211k BBIO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.31 | 6,300 | $185K | 87.3% |
| 2 | $29.74 | 900 | $27K | 12.7% |
| Total | $29.36 avg | 7,200 | $211K | 100% |
| Filing → |
| FTH | BUY | 2026-06-24 | $406K | — | Filing → |
| BBIO | SELL | 2025-02-27 | $282K | — | Filing → |
| BBIO | SELL | 2025-02-19 | $300K | — | Filing → |